In Silico Design of a Trans-Amplifying RNA-Based Vaccine against SARS-CoV-2 Structural Proteins
Nucleic acid-based vaccines allow scalable, rapid, and cell-free vaccine production in response to an emerging disease such as the current COVID-19 pandemic. Here, we objected to the design of a multiepitope mRNA vaccine against the structural proteins of SARS-CoV-2. Through an immunoinformatic appr...
Saved in:
Main Authors: | Fatemeh Nafian, Ghazal Soleymani, Zahra Pourmanouchehri, Mahnaz Kiyanjam, Simin Nafian, Sayed Mohammad Mohammadi, Hanie Jeyroudi, Sharareh Berenji Jalaei, Fatemeh Sabzpoushan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Advances in Virology |
Online Access: | http://dx.doi.org/10.1155/2024/3418062 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel (±)-trans-β-lactam ureas: Synthesis, in silico and in vitro biological profiling
by: Jurin Mladenka, et al.
Published: (2024-03-01) -
Perturbation of EPHA2 and EFNA1 trans binding amplifies inflammatory response in airway epithelial cells
by: Ryosuke Fukuda, et al.
Published: (2025-02-01) -
In Silico Study of Coumarins: Wedelolactone as a Potential Inhibitor of the Spike Protein of the SARS-CoV-2 Variants
by: Saurav Katuwal, et al.
Published: (2023-01-01) -
Promising inhibitors against main protease of SARS CoV-2 from medicinal plants: In silico identification
by: EBENEZER OLUWAKEMI, et al.
Published: (2022-06-01) -
In Silico Study of Alkaloids: Neferine and Berbamine Potentially Inhibit the SARS-CoV-2 RNA-Dependent RNA Polymerase
by: Rishab Marahatha, et al.
Published: (2022-01-01)